Literature DB >> 30563893

Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.

Jagmohan Hooda1, Marián Novak2, Matthew P Salomon3, Chikako Matsuba3, Romela I Ramos3, Emily MacDuffie2, Melissa Song1, Michelle S Hirsch4, Jenny Lester5, Vinita Parkash6, Beth Y Karlan5, Moshe Oren7, Dave S Hoon3, Ronny Drapkin8.   

Abstract

Recent insights supporting the fallopian tube epithelium (FTE) and serous tubal intraepithelial carcinomas (STIC) as the tissue of origin and the precursor lesion, respectively, for the majority of high-grade serous ovarian carcinomas (HGSOC) provide the necessary context to study the mechanisms that drive the development and progression of HGSOC. Here, we investigate the role of the E3 ubiquitin ligase RNF20 and histone H2B monoubiquitylation (H2Bub1) in serous tumorigenesis and report that heterozygous loss of RNF20 defines the majority of HGSOC tumors. At the protein level, H2Bub1 was lost or downregulated in a large proportion of STIC and invasive HGSOC tumors, implicating RNF20/H2Bub1 loss as an early event in the development of serous ovarian carcinoma. Knockdown of RNF20, with concomitant loss of H2Bub1, was sufficient to enhance cell migration and clonogenic growth of FTE cells. To investigate the mechanisms underlying these effects, we performed ATAC-seq and RNA-seq in RNF20 knockdown FTE cell lines. Loss of RNF20 and H2Bub1 was associated with a more open chromatin conformation, leading to upregulation of immune signaling pathways, including IL6. IL6 was one of the key cytokines significantly upregulated in RNF20- and H2Bub1-depleted FTE cells and imparted upon these cells an enhanced migratory phenotype. These studies provide mechanistic insight into the observed oncogenic phenotypes triggered by the early loss of H2Bub1. SIGNIFICANCE: Loss of RNF20 and H2Bub1 contributes to transformation of the fallopian tube epithelium and plays a role in the initiation and progression of high-grade serous ovarian cancer.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/79/4/760/F1.large.jpg. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30563893      PMCID: PMC6377833          DOI: 10.1158/0008-5472.CAN-18-2297

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways.

Authors:  Alexander J Cole; Kristie-Ann Dickson; Christopher Liddle; Clare Stirzaker; Jaynish S Shah; Roderick Clifton-Bligh; Deborah J Marsh
Journal:  Cell Mol Life Sci       Date:  2020-05-26       Impact factor: 9.261

2.  Race-associated molecular changes in gynecologic malignancies.

Authors:  Amma Asare; Hui Yao; Olivia D Lara; Ying Wang; Lin Zhang; Anil K Sood
Journal:  Cancer Res Commun       Date:  2022-02-17

Review 3.  The tubal epigenome - An emerging target for ovarian cancer.

Authors:  Hunter D Reavis; Ronny Drapkin
Journal:  Pharmacol Ther       Date:  2020-03-18       Impact factor: 12.310

4.  Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.

Authors:  Selena Y Lin; Shu-Ching Chang; Stella Lam; Romela Irene Ramos; Kevin Tran; Shuichi Ohe; Matthew P Salomon; Ali Asgar S Bhagat; Chwee Teck Lim; Trevan D Fischer; Leland J Foshag; Christine L Boley; Steven J O'Day; Dave S B Hoon
Journal:  Clin Chem       Date:  2020-01-01       Impact factor: 8.327

Review 5.  Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.

Authors:  Alka Singh; Sameer Gupta; Manisha Sachan
Journal:  Front Cell Dev Biol       Date:  2019-09-19

6.  H2Bub1: Guardian of chromatin accessibility in ovarian cancer.

Authors:  Hunter Reavis; Ronny Drapkin
Journal:  Oncoscience       Date:  2019-08-23

Review 7.  Epigenetic Dysregulation at the Crossroad of Women's Cancer.

Authors:  Rakesh Kumar; Aswathy Mary Paul; Pranela Rameshwar; M Radhakrishna Pillai
Journal:  Cancers (Basel)       Date:  2019-08-16       Impact factor: 6.639

8.  Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.

Authors:  Romela Irene Ramos; Matias A Bustos; Jinfeng Wu; Peter Jones; Shu Ching Chang; Eiji Kiyohara; Kevin Tran; Xiaoqing Zhang; Stacey L Stern; Sivan Izraely; Orit Sagi-Assif; Isaac P Witz; Michael A Davies; Gordon B Mills; Daniel F Kelly; Reiko F Irie; Dave S B Hoon
Journal:  Mol Oncol       Date:  2020-06-05       Impact factor: 6.603

9.  Ring finger 20/ring finger 40/WW domain-containing adaptor with coiled-coil complex interacts with p53 to regulate gene transcription in DNA damage response.

Authors:  Danni Meng; Kun Guo; Die Zhang; Cheng Zhao; Chuanwen Sun; Feng Zhang
Journal:  Oncol Lett       Date:  2021-04-01       Impact factor: 2.967

10.  Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer.

Authors:  Chloe Camille Lepage; Michaela Cora Lynn Palmer; Ally Catherina Farrell; Nicole Marie Neudorf; Zelda Lichtensztejn; Mark William Nachtigal; Kirk James McManus
Journal:  Br J Cancer       Date:  2021-03-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.